Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:174-179

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beierwaltes, W. H.
Right arrow Articles by Sigmon, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beierwaltes, W. H.
Right arrow Articles by Sigmon, D. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*NITRIC OXIDE
*PHENYLEPHRINE

(Hypertension. 1995;25:174-179.)
© 1995 American Heart Association, Inc.


Articles

Nitric Oxide Synthesis Inhibition Blocks Reversal of Two-Kidney, One Clip Renovascular Hypertension After Unclipping

William H. Beierwaltes; D'Anna L. Potter; Oscar A. Carretero; David H. Sigmon

From the Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Mich.

Correspondence to William H. Beierwaltes, PhD, Hypertension and Vascular Research Division, 7121 E&R Building, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202.

Abstract It is well established that two-kidney, one clip renovascular hypertension can be rapidly reversed by unclipping. We hypothesized that rapid renal reperfusion and the subsequent fall in blood pressure are mediated in part by nitric oxide, the endothelium-derived relaxing factor. We tested whether the hypotensive response to unclipping could be blocked by nitric oxide synthesis inhibition using a bolus of 10 mg/kg body wt N{omega}-nitro-L-arginine methyl ester. Rats were made hypertensive by placing a silver clip on the left renal artery. After 4 weeks, they were anesthetized and either not treated (controls) or had nitric oxide synthesis blockade. After 10 minutes, the clip was removed and blood pressure monitored over 60 minutes. Initial pressure in controls was 157±8 mm Hg, and heart rate was 310±21 beats per minute. Unclipping resulted in pressure falling to 125±6 mm Hg within 45 minutes (P<.005). Heart rate was unchanged (312±9 beats per minute). In contrast, nitric oxide synthesis inhibition increased blood pressure from 149±6 to 174±9 mm Hg (P<.001). Unclipping did not change blood pressure, which was 167±8 mm Hg after 60 minutes (P<.005 versus controls), and heart rate remained unchanged (282±13 versus 276±16 beats per minute). We determined the blood flow to the clipped kidneys using radioactive microspheres. Unclipping untreated hypertensive rats resulted in a 10-fold increase in renal blood flow (P<.001), concomitant with a decrease in blood pressure. In rats with nitric oxide synthesis inhibition, unclipping resulted in an increase in renal blood flow that was only a third of that seen in untreated rats, with no change in blood pressure. Our results show that nitric oxide synthesis inhibition eliminates the acute reversal of renovascular hypertension caused by unclipping. This suggests that endothelium-derived nitric oxide may be an important component in the reversal of two-kidney, one clip renovascular hypertension, either by facilitating renal reperfusion or by mediating the systemic response secondary to renal reperfusion.


Key Words: endothelium • endothelium-derived relaxing factor • nitric oxide • hypertension, renovascular • angiotensin • renal circulation




This article has been cited by other articles:


Home page
HypertensionHome page
F. Palm, S. G. Connors, M. Mendonca, W. J. Welch, and C. S. Wilcox
Angiotensin II Type 2 Receptors and Nitric Oxide Sustain Oxygenation in the Clipped Kidney of Early Goldblatt Hypertensive Rats
Hypertension, February 1, 2008; 51(2): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W.-C. Huang and R.-Y. Tsai
Nitric Oxide Synthesis Inhibition Retards Surgical Reversal of One-Kidney Goldblatt Hypertension in Rats
Hypertension, September 1, 1998; 32(3): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Ichihara, J. D. Imig, E. W. Inscho, and L. G. Navar
Interactive Nitric Oxide–Angiotensin II Influences on Renal Microcirculation in Angiotensin II–Induced Hypertension
Hypertension, June 1, 1998; 31(6): 1255 - 1260.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. H. Sigmon and W. H. Beierwaltes
Influence of Nitric Oxide in the Chronic Phase of Two-Kidney, One Clip Renovascular Hypertension
Hypertension, February 1, 1998; 31(2): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L.-T. Dijkhorst-Oei, T. J. Rabelink, P. Boer, and H. A. Koomans
Nifedipine Attenuates Systemic and Renal Vasoconstriction During Nitric Oxide Inhibition in Humans
Hypertension, May 1, 1997; 29(5): 1192 - 1198.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. G. Melaragno and G. D. Fink
Change in Pressor Responsiveness to Angiotensin II as a Determinant of Blood Pressure After Unclipping in Two-Kidney, One Clip Hypertensive Rats
Hypertension, October 1, 1996; 28(4): 656 - 662.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Guan, V. Cachofeiro, M. L. Pucci, P. M. Kaminski, M. S. Wolin, and A. Nasjletti
Nitric Oxide and the Depressor Response to Angiotensin Blockade in Hypertension
Hypertension, January 1, 1996; 27(1): 19 - 24.
[Abstract] [Full Text]